Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor

Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor

US Patent 11484517 · Granted Nov 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy comprising compounds of formula (I) and GLP-1 receptor agoni2025
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agoni2025
Combination therapy comprising compounds of formula (I) and GLP-1 receptor agoni2025
Phosphate derivatives of RORgamma modulators and uses thereof2025
Combination of nitazoxanide and elafibranor for the treatment of immune diseases2025
Pharmaceutical compositions for combination therapy2024
Pharmaceutical compositions for combination therapy2024
Pharmaceutical compositions for combination therapy2024
RORgamma modulators and uses thereof2024
Automated pattern recognition and scoring method of histological images2023
Pharmaceutical compositions for combination therapy2023
Pharmaceutical compositions for combination therapy2023